GPCR
Structure Therapeutics Inc.
Key Financials
Operating Income
$-176560000
↓ 11.6%
Net Income
$-141202000
↓ 15.2%
Total Liabilities
$67.5M
↑ 75.5%
Total Assets
$1.6B
↑ 75.3%
EPS (Diluted)
$-0.80
↓ 2.6%
Cash & Equivalents
$799.6M
↑ 371.7%
Shareholders' Equity
$1.5B
↑ 75.3%
Operating Cash Flow
$-222199000.00
↓ 90.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 424B5 | 5/7/2026 | View on SEC |
| ARS | 4/23/2026 | View on SEC |
| DEF 14A | 4/23/2026 | View on SEC |
| 4 | 4/23/2026 | View on SEC |
| 3 | 4/23/2026 | View on SEC |
| 4 | 4/16/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 4 | 3/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GPCR |
| Company Name | Structure Therapeutics Inc. |
| CIK | 1888886 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | (650) 457-1978 |